Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer.
- 1 June 2000
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 61 (3) , 241-247
- https://doi.org/10.1023/a:1006462023110
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Treatment of Breast CancerNew England Journal of Medicine, 1998
- Doxorubicin-Induced CardiomyopathyNew England Journal of Medicine, 1998
- Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients.Breast Cancer Research and Treatment, 1997
- Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.Journal of Clinical Oncology, 1997
- Current and future trends in the multidisciplinary approach for high-risk breast cancer. The experience of the milan cancer instituteEuropean Journal Of Cancer, 1996
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Infusional 5-fluorouracil in breast cancerCancer Treatment Reviews, 1994
- 5-Fluorouracil by Protracted Venous Infusion: A Review of Recent Clinical StudiesCancer Investigation, 1991
- Reporting results of cancer treatmentCancer, 1981
- Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide AngiocardiographyNew England Journal of Medicine, 1979